Vaxart Inc Earnings
The next earnings date for Vaxart Inc is November 13, 2025.
They are scheduled to announce earnings after the market closes that day.
Analyst Estimates of Vaxart Inc Earnings
Report Date | Estimated Earnings Per Share |
---|
11/13/2025 | $-0.07 |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Vaxart Inc Earnings: Historical
Report Date | Before/After Market | Earnings Per Share | Surprise % |
---|
08/13/2025 | --- | $-0.07 | 22.22% |
08/07/2025 | --- | $0 | 100.00% |
05/12/2025 | After Market | $-0.07 | 0.00% |
03/12/2025 | Before Market | --- | --- |
10/31/2024 | Before Market | $-0.06 | 35.69% |
08/08/2024 | After Market | $-0.09 | -200.00% |
05/13/2024 | After Market | $-0.14 | 0.00% |
03/14/2024 | After Market | $-0.12 | 14.29% |
11/02/2023 | After Market | $-0.11 | 38.89% |
08/03/2023 | After Market | $-0.16 | 11.11% |
05/04/2023 | After Market | $-0.19 | 0.00% |
03/15/2023 | After Market | $-0.18 | 21.74% |
11/08/2022 | After Market | $-0.23 | 4.17% |
08/08/2022 | After Market | $-0.23 | -9.52% |
05/09/2022 | After Market | $-0.20 | -25.00% |
02/24/2022 | After Market | $-0.17 | 0.00% |
11/04/2021 | After Market | $-0.14 | 6.67% |
08/05/2021 | After Market | $-0.13 | 7.14% |
05/03/2021 | Before Market | $-0.14 | -40.00% |
02/25/2021 | After Market | $-0.13 | -62.50% |
11/12/2020 | After Market | $-0.08 | 11.11% |
08/06/2020 | After Market | $-0.12 | -100.00% |
05/12/2020 | After Market | $-0.02 | 50.00% |
03/19/2020 | After Market | $-0.13 | 0.00% |
11/12/2019 | After Market | $-0.32 | 8.57% |
08/08/2019 | After Market | $-0.39 | 22.00% |
05/09/2019 | After Market | $-0.18 | --- |
02/06/2019 | After Market | $-0.69 | 75.87% |
11/09/2018 | After Market | $-0.92 | 47.73% |
08/09/2018 | Before Market | $-1.24 | 56.64% |
05/15/2018 | After Market | $0.49 | 116.90% |
11/02/2017 | Before Market | $-1.54 | 50.00% |
08/31/2017 | After Market | $-1.65 | 22.54% |
05/04/2017 | Before Market | $-1.21 | 47.62% |
02/02/2017 | After Market | $-2.64 | 8.97% |
11/03/2016 | After Market | $-2.86 | 7.14% |
09/13/2016 | After Market | $-1.98 | -173.33% |
05/05/2016 | After Market | $-1.54 | 22.22% |
02/05/2016 | Before Market | $-1.87 | -54.55% |
11/06/2015 | Before Market | $-1.88 | -42.39% |
09/11/2015 | Before Market | $-6.06 | --- |
05/07/2015 | Before Market | $0.38 | --- |
02/05/2015 | Before Market | $2.09 | 311.11% |
11/07/2014 | Before Market | $-2.20 | -66.67% |
09/26/2014 | Before Market | $-3.19 | -61.11% |
05/06/2014 | --- | $0.99 | 132.14% |
02/10/2014 | --- | $-0.04 | 98.78% |
12/16/2013 | --- | $-1.52 | -441.54% |
09/18/2013 | --- | $-2.53 | 8.00% |
05/03/2013 | --- | $0.08 | --- |
03/14/2013 | --- | $1.87 | --- |
11/01/2012 | --- | $-8.22 | --- |
08/02/2012 | --- | $-17.15 | --- |
05/04/2012 | --- | $-5.92 | --- |
03/15/2012 | --- | $-3.10 | --- |
11/02/2011 | --- | $-4.62 | 22.22% |
08/03/2011 | --- | $-7.26 | 24.14% |
05/05/2011 | --- | $3.30 | 127.78% |
03/08/2011 | --- | $-9.90 | -100.00% |
11/03/2010 | --- | $7.92 | 1,300.00% |
08/05/2010 | --- | $-5.28 | -6.67% |
05/06/2010 | --- | $7.26 | 257.14% |
03/10/2010 | --- | $1.32 | 118.18% |
11/05/2009 | --- | $-9.24 | 9.68% |
08/06/2009 | --- | $-7.26 | 24.14% |
05/06/2009 | --- | $-9.24 | -133.33% |
03/11/2009 | --- | $-3.30 | 37.50% |
11/06/2008 | --- | $-1.98 | 83.33% |
08/07/2008 | --- | $-0.66 | 93.75% |
05/08/2008 | --- | $-7.92 | 14.29% |
02/28/2008 | --- | $-4.62 | 41.67% |
11/08/2007 | --- | $-17.16 | -81.40% |
08/01/2007 | --- | $-5.94 | 50.66% |
05/02/2007 | --- | $-11.22 | 11.44% |
03/12/2007 | --- | $-8.58 | 51.25% |
11/14/2006 | --- | $-17.82 | -6.58% |
07/26/2006 | --- | $-15.84 | -28.05% |
04/26/2006 | --- | $-19.80 | -53.01% |
02/23/2006 | --- | $-82.50 | -400.00% |
10/19/2005 | --- | $-17.82 | 10.00% |
07/19/2005 | --- | $-23.10 | -35.25% |
04/20/2005 | --- | $-17.82 | 10.36% |
02/15/2005 | --- | $-19.14 | -36.23% |
10/19/2004 | --- | $-11.88 | 15.86% |
07/20/2004 | --- | $-19.80 | -284.47% |
04/21/2004 | --- | $-5.28 | -100.00% |
02/18/2004 | --- | $1.32 | 100.00% |
10/22/2003 | --- | $3.30 | 386.96% |
07/23/2003 | --- | $-5.28 | -300.00% |
04/23/2003 | --- | $0.66 | 0.00% |
02/19/2003 | --- | $1.98 | 25.32% |
10/23/2002 | --- | $1.32 | 700.00% |
07/24/2002 | --- | $1.32 | 0.00% |
04/24/2002 | --- | $-1.32 | -100.00% |
02/12/2002 | --- | $2.64 | -20.00% |
10/24/2001 | --- | $5.28 | 700.00% |
07/25/2001 | --- | $2.64 | 33.33% |
04/25/2001 | --- | $1.32 | 0.00% |
02/26/2001 | --- | $5.28 | -20.00% |
10/25/2000 | --- | $-0.66 | -120.00% |
07/25/2000 | --- | $1.98 | 0.00% |
03/31/2000 | --- | $1.21 | --- |
10/27/1999 | --- | $2.64 | 14.29% |
07/28/1999 | --- | $1.98 | 0.00% |
03/31/1999 | --- | $-0.97 | --- |
03/01/1999 | --- | $-1.32 | 0.00% |
10/27/1998 | --- | $-7.26 | -466.67% |
07/27/1998 | --- | $-0.66 | --- |
05/04/1998 | --- | $-12.54 | -46.15% |
10/30/1997 | --- | $-4.62 | -115.89% |
08/06/1997 | --- | $3.96 | 4.21% |
04/24/1997 | --- | $2.64 | -43.95% |
02/20/1997 | --- | $6.60 | 12.82% |
10/29/1996 | --- | $5.28 | 74.83% |
07/29/1996 | --- | $3.30 | 13.79% |
04/23/1996 | --- | $2.64 | 60.00% |
02/28/1996 | --- | $-20.46 | -277.14% |
10/26/1995 | Before Market | $11.22 | 6.25% |
07/27/1995 | Before Market | $9.90 | 0.00% |
04/27/1995 | Before Market | $9.90 | 15.38% |
02/15/1995 | Before Market | $9.24 | 23.53% |
10/26/1994 | Before Market | $7.92 | 0.00% |
07/26/1994 | --- | $7.92 | 20.00% |
04/26/1994 | --- | $6.60 | 11.11% |
More About Vaxart Inc
Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.
“Vaxart Inc Earnings” Can Refer to the Vaxart Inc Earnings Date
Some people say “Vaxart Inc earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Vaxart Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Vaxart Inc Stock on the Earnings Date
If you own Vaxart Inc stock (VXRT) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Vaxart Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Vaxart Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Vaxart Inc Earnings
You can contact us any time if you would like to ask questions about Vaxart Inc earnings or anything else related to the stock market.